Sickle Cell Disease

clinical topic updates

by Stella T. Chou, MD

In patients with sickle cell disease (SCD) on chronic transfusion therapy, the hemoglobin variant quantification not only reveals whether the patie......READ MORE

expert roundtables

by Stella T. Chou, MD; Michael Rutledge DeBaun, MD, MPH; and Julie Kanter, MD

Patients with sickle cell disease (SCD) and frequent vaso-occlusive crises (VOCs) require a comprehensive multifaced approach. The best plans are g......READ MORE

patient care perspectives

by Stella T. Chou, MD

A number of advancements have been made in the field of transfusion medicine. Efforts to promote awareness on the judicious use of transfusion ther......READ MORE

clinical topic updates

by Julie Kanter, MD

Thrombotic risk in sickle cell disease (SCD) is not entirely understood; however, findings from clinical trials with antithrombotic agents provide ......READ MORE

expert roundtables

by Stella T. Chou, MD; Michael Rutledge DeBaun, MD, MPH; and Julie Kanter, MD

Established interventions for sickle cell disease (SCD), such as hydroxyurea and chronic transfusion therapy, have greatly improved outcomes. As no......READ MORE